journal article·2023-01

Electrospun fiber-mediated delivery of neurotrophin-3 mRNA for neural tissue engineering applications

Devan L. Puhl, Jessica L. Funnell, Tanner D. Fink, Anuj Swaminathan, Martin Oudega, R. Helen Zha, Ryan J. Gilbert

Acta Biomaterialia· Volume 155
Publisher page

Abstract

Aligned electrospun fibers provide topographical cues and local therapeutic delivery to facilitate robust peripheral nerve regeneration. mRNA delivery enables transient expression of desired proteins that promote axonal regeneration. However, no prior work delivers mRNA from electrospun fibers for peripheral nerve regeneration applications. Here, we developed the first aligned electrospun fibers to deliver pseudouridine-modified (Ψ) neurotrophin-3 (NT-3) mRNA (ΨNT-3mRNA) to primary Schwann cells and assessed NT-3 secretion and bioactivity. We first electrospun aligned poly(L-lactic acid) (PLLA) fibers and coated them with the anionic substrates dextran sulfate sodium salt (DSS) or poly(3,4-dihydroxy-L-phenylalanine) (pDOPA). Cationic lipoplexes containing ΨNT-3mRNA complexed to JetMESSENGER® were then immobilized to the fibers, resulting in detectable ΨNT-3mRNA release for 28 days from all fiber groups investigated (PLLA+mRNA, 0.5DSS4h+mRNA, and 2pDOPA4h+mRNA). The 2pDOPA4h+mRNA group significantly increased Schwann cell secretion of NT-3 for 21 days compared to control PLLA fibers (p < 0.001-0.05) and, on average, increased Schwann cell secretion of NT-3 by ≥ 2-fold compared to bolus mRNA delivery from the 1µgBolus+mRNA and 3µgBolus+mRNA groups. The 2pDOPA4h+mRNA fibers supported Schwann cell secretion of NT-3 at levels that significantly increased dorsal root ganglia (DRG) neurite extension by 44% (p < 0.0001) and neurite area by 64% (p < 0.001) compared to control PLLA fibers. The data show that the 2pDOPA4h+mRNA fibers enhance the ability of Schwann cells to promote neurite growth from DRG, demonstrating this platform's potential capability to improve peripheral nerve regeneration. STATEMENT OF SIGNIFICANCE: Aligned electrospun fibers enhance axonal regeneration by providing structural support and guidance cues, but further therapeutic stimulation is necessary to improve functional outcomes. mRNA delivery enables the transient expression of therapeutic proteins, yet achieving local, sustained delivery remains challenging. Previous work shows that genetic material delivery from electrospun fibers improves regeneration; however, mRNA delivery has not been explored. Here, we examine mRNA delivery from aligned electrospun fibers to enhance neurite outgrowth. We show that immobilization of NT-3mRNA/JetMESSENGER® lipoplexes to aligned electrospun fibers functionalized with pDOPA enables local, sustained NT-3mRNA delivery to Schwann cells, increasing Schwann cell secretion of NT-3 and enhancing DRG neurite outgrowth. This study displays the potential benefits of electrospun fiber-mediated mRNA delivery platforms for neural tissue engineering.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nerve injury and regeneration · Electrospun Nanofibers in Biomedical Applications · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. , National Institute of Neurological Disorders and Stroke. (2021). https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets/Peripheral-Neuropathy-Fact-Sheet (accessed February 11, 2022).
2. Peripheral nerve reconstruction after injury: a review of clinical and experimental therapies10.1155/2014/698256 ↗
3. The anatomy and physiology of nerve injury10.1002/mus.880130903 ↗
4. Repairing injured peripheral nerves: bridging the gap10.1016/j.pneurobio.2010.10.002 ↗
5. Peripheral nerve conduit: materials and structures10.1021/acschemneuro.9b00203 ↗
6. Transmission of infection with human allografts: essential considerations in donor screening10.1093/cid/cis519 ↗
7. Recovery of motor function after mixed and motor nerve repair with processed nerve allograft10.1097/GOX.0000000000002163 ↗
8. Electrospun nerve guide conduits have the potential to bridge peripheral nerve injuries in vivo10.1038/s41598-018-34699-8 ↗
9. Electrospun nanofibers as carriers of microorganisms, stem cells, proteins, and nucleic acids in therapeutic and other applications10.3389/fbioe.2020.00130 ↗
10. Regeneration of the peripheral nerve via multifunctional electrospun scaffolds10.1002/jbm.a.37092 ↗
11. Electrospun nanofibers as versatile interfaces for efficient gene delivery10.1186/1754-1611-8-30 ↗
12. Designing electrospun fiber platforms for efficient delivery of genetic material and genome editing tools10.1016/j.addr.2022.114161 ↗
13. Biomimetic surface delivery of NGF and BDNF to enhance neurite outgrowth10.1002/bit.27466 ↗
14. Heparin-poloxamer thermosensitive hydrogel loaded with bFGF and NGF enhances peripheral nerve regeneration in diabetic rats10.1016/j.biomaterials.2018.03.044 ↗
15. Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury10.1016/j.jconrel.2004.05.003 ↗
16. Delivery of neurotrophin-3 from fibrin enhances neuronal fiber sprouting after spinal cord injury10.1016/j.jconrel.2006.05.005 ↗
17. Neurotrophin-3 delivered locally via fibronectin mats enhances peripheral nerve regeneration10.1111/j.1460-9568.1997.tb01493.x ↗
18. Neurotrophin-3–enhanced nerve regeneration selectively improves recovery of muscle fibers expressing myosin heavy chains 2b10.1083/jcb.139.3.709 ↗
19. Bioactive 3D scaffolds for the delivery of NGF and BDNF to improve nerve regeneration10.3389/fmats.2021.734683 ↗
20. Controlled release of growth factors from multilayered fibrous scaffold for functional recoveries in crushed sciatic nerve10.1021/acsbiomaterials.7b00801 ↗
21. RGD/TAT-functionalized chitosan-graft-PEI-PEG gene nanovector for sustained delivery of NT-3 for potential application in neural regeneration10.1016/j.actbio.2018.03.030 ↗
22. Spatio-temporal release of NGF and GDNF from multi-layered nanofibrous bicomponent electrospun scaffolds10.1007/s10856-018-6105-x ↗
23. The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-310.1016/0092-8674(91)90628-C ↗
24. trkC, a new member of the trk family of tyrosine protein kinases, is a receptor for neurotrophin-310.1016/0092-8674(91)90442-2 ↗
25. The trk tyrosine protein kinase mediates the mitogenic properties of nerve growth factor and neurotrophin-310.1016/0092-8674(91)90149-S ↗
26. Neurotrophin signaling and cell survival
27. Dose-dependent differential effect of neurotrophic factors on in vitro and in vivo regeneration of motor and sensory neurons10.1155/2016/4969523 ↗
28. Adenoviral vector-directed expression of neurotrophin-3 in rat dorsal root ganglion explants results in a robust neurite outgrowth response10.1002/(SICI)1097-4695(199708)33:2<172::AID-NEU6>3.0.CO;2-# ↗
29. Neurotrophin 3 activation of TrkC induces Schwann cell migration through the c-Jun N-terminal kinase pathway10.1073/pnas.2336152100 ↗
30. Neurotrophins are key mediators of the myelination program in the peripheral nervous system10.1073/pnas.251543398 ↗
31. Neurotrophin 3 supports the survival of developing muscle sensory neurons in culture10.1073/pnas.90.7.2613 ↗
32. Inhibition of sensory neuron apoptosis and prevention of loss by NT-3 administration following axotomy10.1006/exnr.1998.6985 ↗
33. Effects of systemically administered NT-3 on sensory neuron loss and nestin expression following axotomy10.1002/cne.20400 ↗
34. Two-tiered inhibition of axon regeneration at the dorsal root entry zone10.1523/JNEUROSCI.21-08-02651.2001 ↗
35. NT-3 promotes nerve regeneration and sensory improvement in CMT1A mouse models and in patients10.1212/01.WNL.0000171978.70849.c5 ↗
36. AAV1.NT-3 gene therapy for Charcot–Marie–Tooth neuropathy10.1038/mt.2013.250 ↗
37. Neurotrophin-3 deficient Schwann cells impair nerve regeneration10.1016/j.expneurol.2008.04.015 ↗
38. The impact of neurotrophin-3 on the dorsal root transitional zone following injury10.1038/sc.2008.57 ↗
39. Dependence of regenerated sensory axons on continuous neurotrophin-3 delivery10.1523/JNEUROSCI.5041-11.2012 ↗
40. Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF10.1016/0169-328X(95)00250-V ↗
41. AAV-mediated NT-3 overexpression protects cochleae against noise-induced synaptopathy10.1038/s41434-018-0012-0 ↗
42. Construction of a eukaryotic expression plasmid for human retina-derived neurotrophin-3
43. Therapeutic effects of simultaneous delivery of nerve growth factor mRNA and protein via exosomes on cerebral ischemia10.1016/j.omtn.2020.06.013 ↗
44. Delivery of synthetic mRNAs for tissue regeneration10.1016/j.addr.2021.114007 ↗
45. Treatment of ischemic neuronal death by introducing brain-derived neurotrophic factor mRNA using polyplex nanomicelle10.1016/j.biomaterials.2021.120681 ↗
46. Enhancement of motor function recovery after spinal cord injury in mice by delivery of brain-derived neurotrophic factor mRNA10.1016/j.omtn.2019.06.016 ↗
47. mRNA-based therapeutics–developing a new class of drugs10.1038/nrd4278 ↗
48. A simple, highly efficient method for heterologous expression in mammalian primary neurons using cationic lipid-mediated mRNA transfection10.3389/fnins.2010.00181 ↗
49. Gene therapy leaves a vicious cycle10.3389/fonc.2019.00297 ↗
50. Messenger RNA delivery for tissue engineering and regenerative medicine applications10.1089/ten.tea.2017.0444 ↗
51. Cationic liposome-mediated RNA transfection10.1073/pnas.86.16.6077 ↗
52. Biomaterials for mRNA delivery10.1039/C5BM00198F ↗
53. Delivery of messenger RNA using poly(ethylene imine)–poly(ethylene glycol)-copolymer blends for polyplex formation: Biophysical characterization and in vitro transfection properties10.1016/j.jconrel.2010.09.007 ↗
54. In-vitro transcribed mRNA delivery using PLGA/PEI nanoparticles into human monocyte-derived dendritic cells
55. Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability10.1038/mt.2008.200 ↗
56. Suppression of RNA recognition by toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA10.1016/j.immuni.2005.06.008 ↗
57. Opportunities and challenges in the delivery of mRNA-based vaccines10.3390/pharmaceutics12020102 ↗
58. Three-dimensional aligned nanofibers-hydrogel scaffold for controlled non-viral drug/gene delivery to direct axon regeneration in spinal cord injury treatment10.1038/srep42212 ↗
59. A 3D fiber-hydrogel based non-viral gene delivery platform reveals that microRNAs promote axon regeneration and enhance functional recovery following spinal cord injury
60. Microenvironment-responsive immunoregulatory electrospun fibers for promoting nerve function recovery10.1038/s41467-020-18265-3 ↗
61. Biomimicking fiber scaffold as an effective in vitro and in vivo microRNA screening platform for directing tissue regeneration
62. Creation of highly aligned electrospun poly-L-lactic acid fibers for nerve regeneration applications10.1088/1741-2560/6/1/016001 ↗
63. Robust CNS regeneration after complete spinal cord transection using aligned poly-l-lactic acid microfibers10.1016/j.biomaterials.2011.05.006 ↗
64. Biodegradation and biocompatibility of poly l-lactic acid implantable mesh10.5213/inj.1734882.441 ↗
65. Mussel-inspired modification of nanofibers for REST siRNA delivery: Understanding the effects of gene-silencing and substrate topography on human mesenchymal stem cell neuronal commitment10.1002/mabi.201500101 ↗
66. Scaffold mediated gene knockdown for neuronal differentiation of human neural progenitor cells10.1039/C8BM01034J ↗
67. Nanofiber-mediated microRNA delivery to enhance differentiation and maturation of oligodendroglial precursor cells10.1016/j.jconrel.2015.03.005 ↗
68. Topographical effects on fiber-mediated microRNA delivery to control oligodendroglial precursor cells development10.1016/j.biomaterials.2015.08.029 ↗
69. Sustained delivery of siRNA/mesoporous silica nanoparticle complexes from nanofiber scaffolds for long-term gene silencing10.1016/j.actbio.2018.05.054 ↗
70. Scaffold-mediated non-viral delivery platform for CRISPR/Cas9-based genome editing10.1016/j.actbio.2019.04.020 ↗
71. Immobilization of lysozyme on layer-by-layer self-assembled electrospun nanofibers treated by post-covalent crosslinking10.1016/j.foodhyd.2021.106999 ↗
72. Multivariate analysis reveals topography dependent relationships amongst neurite morphological features from dorsal root ganglia neurons10.1088/1741-2552/ac7078 ↗
73. Electrospun nanofiber scaffolds for investigating cell–matrix adhesion
74. Combination of engineered Schwann cell grafts to secrete neurotrophin and chondroitinase promotes axonal regeneration and locomotion after spinal cord injury10.1523/JNEUROSCI.2661-13.2014 ↗
75. Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerve10.1016/0006-8993(79)90048-9 ↗
76. Schwann cell but not olfactory ensheathing glia transplants improve hindlimb locomotor performance in the moderately contused adult rat thoracic spinal cord10.1523/JNEUROSCI.22-15-06670.2002 ↗
77. Exploring the effects of electrospun fiber surface nanotopography on neurite outgrowth and branching in neuron cultures
78. The repair Schwann cell and its function in regenerating nerves10.1113/JP270874 ↗
79. The success and failure of the Schwann cell response to nerve injury10.3389/fncel.2019.00033 ↗
80. Modern trends for peripheral nerve repair and regeneration: beyond the hollow nerve guidance conduit10.3389/fbioe.2019.00337 ↗
81. Vastly extended drug release from poly(pro-17β-estradiol) materials facilitates in vitro neurotrophism and neuroprotection10.1038/s41467-019-12835-w ↗
82. Varying the diameter of aligned electrospun fibers alters neurite outgrowth and Schwann cell migration10.1016/j.actbio.2010.02.020 ↗
83. The limitless future of RNA therapeutics10.3389/fbioe.2021.628137 ↗
84. mRNA, a revolution in biomedicine10.3390/pharmaceutics13122090 ↗
85. mRNA – a game changer in regenerative medicine, cell-based therapy and reprogramming strategies10.1016/j.addr.2021.114002 ↗
86. Emergence of synthetic mRNA: in vitro synthesis of mRNA and its applications in regenerative medicine10.1016/j.biomaterials.2017.11.034 ↗
87. Nanoparticles versus dendritic cells as vehicles to deliver mRNA encoding multiple epitopes for immunotherapy10.1016/j.omtm.2019.10.015 ↗
88. Optimized conditions for successful transfection of human endothelial cells with in vitro synthesized and modified mRNA for induction of protein expression10.1186/1754-1611-8-8 ↗
89. Role of lipid-based and polymer-based non-viral vectors in nucleic acid delivery for next-generation gene therapy10.3390/molecules25122866 ↗
90. Next-generation vaccines: nanoparticle-mediated DNA and mRNA delivery10.1002/adhm.202001812 ↗
91. Nucleic acid delivery
92. Physisorption of hydroxide ions from aqueous solution to a hydrophobic surface10.1021/ja044426f ↗
93. Structure and charging of hydrophobic material/water interfaces studied by phase-sensitive sum-frequency vibrational spectroscopy10.1073/pnas.0901480106 ↗
94. Green synthesis of Pd/Fe3O4 composite based on polyDOPA functionalized reduced graphene oxide for electrochemical detection of nitrite in cured food10.1016/j.electacta.2017.09.185 ↗
95. Polydopamine- and polyDOPA-coated electrospun poly(vinyl alcohol) nanofibrous membranes for cationic dye removal10.1016/j.polymertesting.2020.106627 ↗
96. Facile conjugation of biomolecules onto surfaces via mussel adhesive protein inspired coatings10.1002/adma.200801222 ↗
97. Mussel-inspired surface chemistry for multifunctional coatings10.1126/science.1147241 ↗
98. Polydopamine—a nature-inspired polymer coating for biomedical science10.1039/c1nr10969c ↗
99. Electrospun fibers for spinal cord injury research and regeneration10.1089/neu.2015.4165 ↗
100. Electrospun fiber scaffolds for engineering glial cell behavior to promote neural regeneration10.3390/bioengineering8010004 ↗